AbbVie Inc.
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Adjusted After-Tax Earnings — Non-GAAP by Year
Adjusted After-Tax Earnings — Non-GAAP ($M) ($M)
AbbVie Adjusted After-Tax Earnings — Non-GAAP: $17,784M in FY2025, down 1.2% from a year earlier.
Where the FY2025 figure comes from
“|| As adjusted (non-GAAP) | $ | 21,692 | $ | 17,784 | $ | 10.00”
Source: Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗
Reported in Form 8-K Non-GAAP Reconciliations.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Adjusted After-Tax Earnings — Non-GAAP ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17,784 | -1.2% | Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗ |
| FY2024 | Dec 31, 2024 | 18,001 | -8.9% | Form 8-K (abbv-20241231xexhibit991.htm, filed 2025-01-31) ↗ |
| FY2023 | Dec 31, 2023 | 19,769 | -19.6% | Form 8-K (abbv-20231231xexhibit991.htm, filed 2024-02-02) ↗ |
| FY2022 | Dec 31, 2022 | 24,597 | – | Form 8-K (abbv-20221231xexhibit991.htm, filed 2023-02-09) ↗ |
Breakdown
What makes up adjusted After-Tax Earnings — Non-GAAP
- Reported After-Tax Earnings — GAAP ($M)4,226 · FY2025
- Adjusted Pre-Tax Earnings — Non-GAAP ($M)21,692 · FY2025
- Reported Pre-Tax Earnings — GAAP ($M)6,597 · FY2025
- Adjusted Cost of Products Sold — Non-GAAP ($M)21,692 · FY2025
- Adjusted SG&A Expense — Non-GAAP ($M)3,901 · FY2025
- Adjusted Income Tax Expense — Non-GAAP ($M)3,901 · FY2025
Cite this data
StockData. (2026). AbbVie Adjusted After-Tax Earnings — Non-GAAP ($M), annual FY2022–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/nongaap-adj-aftertax
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.